INVESTMENT
The CDTI SICC Innvierte of investing in Innovation, along with Nanoligent INVEREADY BIOTECH IV PARALLEL, SCR, S.A. and INVEREADY BIOTECH IV, SCR S.A., in order to develop an oncological nanofármaco
The contribution of CDTI innovation in this operation is eur 3.6 million
Ver sección
The CDTI SICC Innvierte of investing in Innovation KIBO VENTURES FUND IV INNVIERTE, F.C.R.E., fund focused on business cyber DeepTech as artificial intelligence, robotics, climate, health, education and other disruptive technologies
The CDTI innovation has committed an investment of up to eur 73.5 million in the fund
Ver sección
The CDTI SICC Innvierte of Innovation invests in SC NET ZERO VENTURES FUND I, F.C.R.E., fund focused on climate technologies that drive the decarbonisation of industry, energy transition and mobility in europe
The CDTI innovation has committed an investment of up to €20 million in the fund
Ver sección
The CDTI SICC Innvierte of investing in Innovation 4FOUNDERS CAPITAL FUND III, F.C.R.E., fund focused on technology startups B2B models use SaaS and strong ai
The CDTI innovation has committed an investment of up to 14.75 million euros in the fund
Ver sección
The CDTI SICC Innvierte of investing in Innovation Ona Pharmaceuticals, together with five coinversores, to develop new innovative therapies using ADCs that attack cancer advanced
The contribution of CDTI innovation in this operation is eur 10 million
Ver sección
The CDTI SICC Innvierte of investing in Innovation 011h, together with five coinversores, to promote a digital platform addressed to the design and construction of buildings
The contribution of CDTI innovation in this operation is €5.436.000
Ver sección
The CDTI SICC Innvierte of investing in Innovation X1 WIND, together with CLUB RG 14, S.L., to develop a floating wind system proved innovative and ready to change the paradigm of offshore wind industry
The contribution of CDTI Innovation in this exercise is €405,000
Ver sección
The CDTI SICC Innvierte of investing in Innovation Integrates Pharmaceuticals, along with three coinversores, to develop a platform of gene edition for the treatment of oncology diseases, immune and of genetic origin
The contribution of CDTI innovation in this operation is eur 2.7 million
Ver sección
The CDTI SICC Innvierte of Innovation invests in KOA Biotech, together with SWANLAAB INNVIERTE AGRIFOOD TECH, F.C.R. devices, to develop monitoring that drive preventive health care in aquaculture
The contribution of CDTI innovation in this operation is €500,000
Ver sección
Subscribe to INVESTMENT